Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PVP Ventures Ltd Capital/Financing Update 2025

May 5, 2025

61131_rns_2025-05-05_d40acb87-1982-4d7b-b7fa-07f49d1460e7.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

05[th] May, 2025

==> picture [414 x 47] intentionally omitted <==

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Kala Ghoda, Fort, Mumbai – 400001 Equity - Scrip Code: 517556

National Stock Exchange Limited “Exchange Plaza, Bandra Kurla Complex, Bandra (E) Mumbai – 400051 Equity-Symbol: PVP

Debt- 18PVL29A, 18PVL29

Subject: Intimation under Regulation 30 & 51 of SEBI (Listing Obligations and “ ” Disclosures Requirements) Regulations, 2015 ( Listing Regulations ) – Acquisition of Optimus Oncology Private Limited

This update is in continuation to our earlier communication dated 23[rd] April 2025, with respect to acquisition of Optimus Oncology Private Limited.

We wish to inform you that, today the Company has acquired 46,70,761 Equity Shares in Optimus Oncology Private Limited by paying the total consideration amount of Rs.54,73,66,481/- (Rupees Fifty Four Crores Seventy Three Lakhs Sixty Six Thousand Four Hundred and Eighty One Only).

By virtue of acquiring a substantial stake in Optimus Oncology Private Limited, the Company Optimus Oncology Private Limited becomes the subsidiary of PVP Ventures Limited with effect from today i.e. 05[th] May 2025.

Request you to kindly take the same on record.

Thanking You,

For PVP Ventures Limited

PRASAD VEERA Digitally signed by PRASAD VEERA POTLURI POTLURI Date: 2025.05.05 17:51:41 +05'30' Prasad V Potluri Chairman & Managing Director

==> picture [425 x 96] intentionally omitted <==